{"resourceType":"ValueSet","id":"2.16.840.1.113883.3.464.1003.196.11.1237","meta":{"versionId":"62","lastUpdated":"2021-11-02T01:01:51.000-04:00"},"url":"http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.464.1003.196.11.1237","version":"20211102","name":"Carbinoxamine","status":"active","date":"2021-11-02T01:01:51-04:00","publisher":"NCQA PHEMUR","compose":{"include":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","version":"05022022","concept":[{"code":"1010696","display":"carbinoxamine maleate 0.8 MG/ML Oral Solution"},{"code":"1012904","display":"carbinoxamine maleate 4 MG Oral Tablet"},{"code":"1374770","display":"12 HR carbinoxamine maleate 0.8 MG/ML Extended Release Suspension"},{"code":"1795581","display":"carbinoxamine maleate 6 MG Oral Tablet"},{"code":"359329","display":"carbetapentane citrate 4 MG/ML / guaifenesin 20 MG/ML Oral Solution"}]}]}}